Literature DB >> 17219972

Association between up-regulation of Fas ligand expression and apoptosis of tumor-infiltrating lymphocytes in human breast cancer.

Bo Cheng1.   

Abstract

In order to study the significance of FasL expression in immune escape of breast cancer, FasL protein expression and the number of tumor-infiltrating lymphocytes (TILs) in 40 specimens of breast cancer were detected by immunohistochemitry. The expression of FasL mRNA was measured by in situ hybridization in the consecutive tissue slices of 40 breast cancers respectively. By using terminal deoxynucleotidyl transferase-mediaed dUTP nick end labeling (TUNEL), apoptotic cells were detected in 40 specimens of breast cancer. The expression of FasL was detected in all 40 specimens to varying degrees. In the consecutive tissue slices, the location of expression of FasL protein corresponded with that of FasL mRNA. In those with FasL extensive expression, the number of TILs was less (P<0.05), the apoptotic index (AI) of TILs was higher and the AI of tumor cells was lower (P<0.01) than those with FasL weak expression respectively. The AI of TILs was correlated with that of tumor cells (r= -0.629, P<0.01). In conclusion, breast cancer cells can induce the apoptosis of TILs through the expression of FasL, which can counterattack the immune system. This may be a mechanism of immune evasion in breast cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17219972     DOI: 10.1007/s11596-006-0524-5

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  6 in total

1.  Fas-related apoptosis in gastric adenocarcinoma.

Authors:  Sung-Chul Lim
Journal:  Oncol Rep       Date:  2003 Jan-Feb       Impact factor: 3.906

2.  Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer.

Authors:  K M Ropponen; M J Eskelinen; P K Lipponen; E Alhava; V M Kosma
Journal:  J Pathol       Date:  1997-07       Impact factor: 7.996

3.  Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer.

Authors:  M W Bennett; J O'connell; G C O'sullivan; D Roche; C Brady; J Kelly; J K Collins; F Shanahan
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

4.  Fas-mediated apoptosis of melanoma cells and infiltrating lymphocytes in human malignant melanomas.

Authors:  Tetsuo Shukuwa; Ichiro Katayama; Takehiko Koji
Journal:  Mod Pathol       Date:  2002-04       Impact factor: 7.842

5.  Fas (Apo-1/CD95) and Fas ligand interaction between gastric cancer cells and immune cells.

Authors:  Tae-Bum Lee; Young-Don Min; Sung-Chul Lim; Kyung-Jong Kim; Ho-Jong Jeon; Seok-Min Choi; Cheol-Hee Choi
Journal:  J Gastroenterol Hepatol       Date:  2002-01       Impact factor: 4.029

6.  Fas ligand expression in human pancreatic cancer.

Authors:  Tetsuo Ohta; Ayman Elnemr; Hirohisa Kitagawa; Masato Kayahara; Hiroyuki Takamura; Takashi Fujimura; Gen-Ichi Nishimura; Koichi Shimizu; Shuang-Qin Yi; Koichi Miwa
Journal:  Oncol Rep       Date:  2004-10       Impact factor: 3.906

  6 in total
  2 in total

1.  TRAIL protein expression in breast cancer cells correlates with nuclear grade.

Authors:  Adam Bilski; Grażyna Pasz-Walczak; Robert Kubiak; Piotr Sek; Justyna Chalubinska; Wojciech Fendler; Konrad Wronski; Anna Piekarska; Piotr Pluta; Piotr Potemski; Arkadiusz Jeziorski; Janusz Piekarski
Journal:  Arch Med Sci       Date:  2010-09-07       Impact factor: 3.318

Review 2.  Restoring Lost Anti-HER-2 Th1 Immunity in Breast Cancer: A Crucial Role for Th1 Cytokines in Therapy and Prevention.

Authors:  Nadia F Nocera; M Catherine Lee; Lucy M De La Cruz; Cinthia Rosemblit; Brian J Czerniecki
Journal:  Front Pharmacol       Date:  2016-10-06       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.